Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson's disease. Sawamoto N, Doi D, Nakanishi E, Sawamura M, et al. Nature 2025 Apr 16. doi: 10.1038/s41586-025-08700.

Read + Share

Amedeo Smart

Independent Medical Education

Sawamoto N, Doi D, Nakanishi E, Sawamura M, et al. Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson's disease. Nature 2025 Apr 16. doi: 10.1038/s41586-025-08700.
PMID: 40240591